Purpose: We aimed to derive insights by analyzing the results of a patient safety awareness survey conducted by the Regional Patient Safety Center of the Korean Medical Association. Methods: Survey questions were developed in three domains: sociodemographic characteristics, patient safety awareness, and patient safety education needs. An online anonymous survey targeting Korean physicians was conducted annually from 2021 to 2023. Chi-square tests were used to verify differences in responses by year and sociodemographic characteristics. Results: A total of 774 physicians participated in the survey over the three-year period. Approximately half of the participants were still assessed to have insufficient knowledge about patient safety, and no clear year-over-year improvement was observed. Additionally, while patient safety incidents appeared common, the proportion of respondents who reported incidents remained around 20%. However, participants showed high levels of agreement or engagement in patient participation activities related to patient safety (over 90%), with 60% having previously received patient safety-related education, and nearly 90% expressing willingness to participate in future education. The findings also highlighted a particular urgency in improving patient safety awareness among clinic-based physicians. Conclusion Promoting awareness of patient safety incident reporting methods and encouraging clinic-based physicians to report incidents should be prioritized. The study’s findings will provide a foundation for more effectively fostering physician engagement in patient safety improvement activities.

Objective: Non-pharmacological interventions (NPIs) are effective in treating gaming disorder (GD). However, studies have not comprehensively evaluated the most effective NPIs. This systematic review and meta-analysis aimed to evaluate the effects of NPIs on the prevention and reduction of GD in the general population with GD. Methods: We searched five databases (MEDLINE, Embase, Cochrane CENTRAL, PsycINFO, and CINAHL) for English-language randomized controlled trials (RCTs) published till May 12, 2024, using Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Two independent reviewers selected studies, extracted data, and assessed quality using the Cochrane Risk of Bias Tool (RoB2). Meta-analyses were conducted using a random-effect model, with effect sizes calculated using Hedges’s g and heterogeneity assessed using I2 statistics. Results: A total of 18 RCTs involving 1,950 participants were included. The NPIs included psychotherapy, behavioral interventions, and other strategies. The pooled analysis showed a significant reduction in GD severity (Hedges’s g=-0.82; 95% confidence interval, -1.23 to -0.52; I2=90.36%). Psychotherapy, particularly cognitive-behavioral therapy, showed the most substantial effect (10 studies, 1,036 participants; Hedges’s g=-1.34). Behavioral interventions (4 studies, 456 participants) and prevention-focused interventions (6 studies, 1,164 participants) had smaller but positive effects. Subgroup analyses revealed greater effectiveness of treatment interventions in adults than in adolescents. Sensitivity analyses confirmed the robustness of these results despite high heterogeneity (I2=90.36%). Conclusion NPIs, particularly psychotherapy, are effective in reducing GD severity. However, more high-quality RCTs are needed robust, evidence-based treatment guidelines.

Objective: Non-pharmacological interventions (NPIs) are effective in treating gaming disorder (GD). However, studies have not comprehensively evaluated the most effective NPIs. This systematic review and meta-analysis aimed to evaluate the effects of NPIs on the prevention and reduction of GD in the general population with GD. Methods: We searched five databases (MEDLINE, Embase, Cochrane CENTRAL, PsycINFO, and CINAHL) for English-language randomized controlled trials (RCTs) published till May 12, 2024, using Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Two independent reviewers selected studies, extracted data, and assessed quality using the Cochrane Risk of Bias Tool (RoB2). Meta-analyses were conducted using a random-effect model, with effect sizes calculated using Hedges’s g and heterogeneity assessed using I2 statistics. Results: A total of 18 RCTs involving 1,950 participants were included. The NPIs included psychotherapy, behavioral interventions, and other strategies. The pooled analysis showed a significant reduction in GD severity (Hedges’s g=-0.82; 95% confidence interval, -1.23 to -0.52; I2=90.36%). Psychotherapy, particularly cognitive-behavioral therapy, showed the most substantial effect (10 studies, 1,036 participants; Hedges’s g=-1.34). Behavioral interventions (4 studies, 456 participants) and prevention-focused interventions (6 studies, 1,164 participants) had smaller but positive effects. Subgroup analyses revealed greater effectiveness of treatment interventions in adults than in adolescents. Sensitivity analyses confirmed the robustness of these results despite high heterogeneity (I2=90.36%). Conclusion NPIs, particularly psychotherapy, are effective in reducing GD severity. However, more high-quality RCTs are needed robust, evidence-based treatment guidelines.

Objective: Non-pharmacological interventions (NPIs) are effective in treating gaming disorder (GD). However, studies have not comprehensively evaluated the most effective NPIs. This systematic review and meta-analysis aimed to evaluate the effects of NPIs on the prevention and reduction of GD in the general population with GD. Methods: We searched five databases (MEDLINE, Embase, Cochrane CENTRAL, PsycINFO, and CINAHL) for English-language randomized controlled trials (RCTs) published till May 12, 2024, using Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Two independent reviewers selected studies, extracted data, and assessed quality using the Cochrane Risk of Bias Tool (RoB2). Meta-analyses were conducted using a random-effect model, with effect sizes calculated using Hedges’s g and heterogeneity assessed using I2 statistics. Results: A total of 18 RCTs involving 1,950 participants were included. The NPIs included psychotherapy, behavioral interventions, and other strategies. The pooled analysis showed a significant reduction in GD severity (Hedges’s g=-0.82; 95% confidence interval, -1.23 to -0.52; I2=90.36%). Psychotherapy, particularly cognitive-behavioral therapy, showed the most substantial effect (10 studies, 1,036 participants; Hedges’s g=-1.34). Behavioral interventions (4 studies, 456 participants) and prevention-focused interventions (6 studies, 1,164 participants) had smaller but positive effects. Subgroup analyses revealed greater effectiveness of treatment interventions in adults than in adolescents. Sensitivity analyses confirmed the robustness of these results despite high heterogeneity (I2=90.36%). Conclusion NPIs, particularly psychotherapy, are effective in reducing GD severity. However, more high-quality RCTs are needed robust, evidence-based treatment guidelines.

In October 2024, the World Medical Association’s Declaration of Helsinki (DoH) underwent comprehensive updates that incorporated feedback from global experts and stakeholders. The revised DoH continues to serve as a cornerstone for international and national regulations on medical research ethics. This paper aims to delve into the 2024 amendments to DoH and assesses their impact on South Korea’s Bioethics and Safety Act (Bioethics Act). This paper analyses the congruences and gaps between the revised DoH and the current Bioethics Act, examining the alignment and gaps between the current Bioethics Act and the revised DoH.This study identified necessary revisions to enhance the ethical conduct of medical research in Korea in accordance with international standards. A comparison between the principles of the revised DoH and the provisions of the Bioethics Act revealed essential adjustments required to align the Bioethics Act with updated ethical guidelines. These findings underscore the broader implications for Korea's regulatory framework on human research ethics, emphasizing the need for a strategic integration of global ethical standards into the country’s legal structure.The revised DoH emphasizes the active role of research participants and the fair inclusion of vulnerable groups. In Korea, the Bioethics Act, last revised in 2013, aligns closely with the DoH but requires further updates to reflect the 2024 amendments.

In October 2024, the World Medical Association’s Declaration of Helsinki (DoH) underwent comprehensive updates that incorporated feedback from global experts and stakeholders. The revised DoH continues to serve as a cornerstone for international and national regulations on medical research ethics. This paper aims to delve into the 2024 amendments to DoH and assesses their impact on South Korea’s Bioethics and Safety Act (Bioethics Act). This paper analyses the congruences and gaps between the revised DoH and the current Bioethics Act, examining the alignment and gaps between the current Bioethics Act and the revised DoH.This study identified necessary revisions to enhance the ethical conduct of medical research in Korea in accordance with international standards. A comparison between the principles of the revised DoH and the provisions of the Bioethics Act revealed essential adjustments required to align the Bioethics Act with updated ethical guidelines. These findings underscore the broader implications for Korea's regulatory framework on human research ethics, emphasizing the need for a strategic integration of global ethical standards into the country’s legal structure.The revised DoH emphasizes the active role of research participants and the fair inclusion of vulnerable groups. In Korea, the Bioethics Act, last revised in 2013, aligns closely with the DoH but requires further updates to reflect the 2024 amendments.

In October 2024, the World Medical Association’s Declaration of Helsinki (DoH) underwent comprehensive updates that incorporated feedback from global experts and stakeholders. The revised DoH continues to serve as a cornerstone for international and national regulations on medical research ethics. This paper aims to delve into the 2024 amendments to DoH and assesses their impact on South Korea’s Bioethics and Safety Act (Bioethics Act). This paper analyses the congruences and gaps between the revised DoH and the current Bioethics Act, examining the alignment and gaps between the current Bioethics Act and the revised DoH.This study identified necessary revisions to enhance the ethical conduct of medical research in Korea in accordance with international standards. A comparison between the principles of the revised DoH and the provisions of the Bioethics Act revealed essential adjustments required to align the Bioethics Act with updated ethical guidelines. These findings underscore the broader implications for Korea's regulatory framework on human research ethics, emphasizing the need for a strategic integration of global ethical standards into the country’s legal structure.The revised DoH emphasizes the active role of research participants and the fair inclusion of vulnerable groups. In Korea, the Bioethics Act, last revised in 2013, aligns closely with the DoH but requires further updates to reflect the 2024 amendments.

Purpose: We aimed to derive insights by analyzing the results of a patient safety awareness survey conducted by the Regional Patient Safety Center of the Korean Medical Association. Methods: Survey questions were developed in three domains: sociodemographic characteristics, patient safety awareness, and patient safety education needs. An online anonymous survey targeting Korean physicians was conducted annually from 2021 to 2023. Chi-square tests were used to verify differences in responses by year and sociodemographic characteristics. Results: A total of 774 physicians participated in the survey over the three-year period. Approximately half of the participants were still assessed to have insufficient knowledge about patient safety, and no clear year-over-year improvement was observed. Additionally, while patient safety incidents appeared common, the proportion of respondents who reported incidents remained around 20%. However, participants showed high levels of agreement or engagement in patient participation activities related to patient safety (over 90%), with 60% having previously received patient safety-related education, and nearly 90% expressing willingness to participate in future education. The findings also highlighted a particular urgency in improving patient safety awareness among clinic-based physicians. Conclusion Promoting awareness of patient safety incident reporting methods and encouraging clinic-based physicians to report incidents should be prioritized. The study’s findings will provide a foundation for more effectively fostering physician engagement in patient safety improvement activities.

Objective: Non-pharmacological interventions (NPIs) are effective in treating gaming disorder (GD). However, studies have not comprehensively evaluated the most effective NPIs. This systematic review and meta-analysis aimed to evaluate the effects of NPIs on the prevention and reduction of GD in the general population with GD. Methods: We searched five databases (MEDLINE, Embase, Cochrane CENTRAL, PsycINFO, and CINAHL) for English-language randomized controlled trials (RCTs) published till May 12, 2024, using Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Two independent reviewers selected studies, extracted data, and assessed quality using the Cochrane Risk of Bias Tool (RoB2). Meta-analyses were conducted using a random-effect model, with effect sizes calculated using Hedges’s g and heterogeneity assessed using I2 statistics. Results: A total of 18 RCTs involving 1,950 participants were included. The NPIs included psychotherapy, behavioral interventions, and other strategies. The pooled analysis showed a significant reduction in GD severity (Hedges’s g=-0.82; 95% confidence interval, -1.23 to -0.52; I2=90.36%). Psychotherapy, particularly cognitive-behavioral therapy, showed the most substantial effect (10 studies, 1,036 participants; Hedges’s g=-1.34). Behavioral interventions (4 studies, 456 participants) and prevention-focused interventions (6 studies, 1,164 participants) had smaller but positive effects. Subgroup analyses revealed greater effectiveness of treatment interventions in adults than in adolescents. Sensitivity analyses confirmed the robustness of these results despite high heterogeneity (I2=90.36%). Conclusion NPIs, particularly psychotherapy, are effective in reducing GD severity. However, more high-quality RCTs are needed robust, evidence-based treatment guidelines.

In October 2024, the World Medical Association’s Declaration of Helsinki (DoH) underwent comprehensive updates that incorporated feedback from global experts and stakeholders. The revised DoH continues to serve as a cornerstone for international and national regulations on medical research ethics. This paper aims to delve into the 2024 amendments to DoH and assesses their impact on South Korea’s Bioethics and Safety Act (Bioethics Act). This paper analyses the congruences and gaps between the revised DoH and the current Bioethics Act, examining the alignment and gaps between the current Bioethics Act and the revised DoH.This study identified necessary revisions to enhance the ethical conduct of medical research in Korea in accordance with international standards. A comparison between the principles of the revised DoH and the provisions of the Bioethics Act revealed essential adjustments required to align the Bioethics Act with updated ethical guidelines. These findings underscore the broader implications for Korea's regulatory framework on human research ethics, emphasizing the need for a strategic integration of global ethical standards into the country’s legal structure.The revised DoH emphasizes the active role of research participants and the fair inclusion of vulnerable groups. In Korea, the Bioethics Act, last revised in 2013, aligns closely with the DoH but requires further updates to reflect the 2024 amendments.